FDA Adverse Event Injury Summary report: N

CFN Ø12 L380 TAN GREEN

MDR report key: 2852718 · Received November 30, 2012

Report

Report Number
2520274-2012-03462
Event Type
Injury
Date Received
November 30, 2012
Date of Event
November 14, 2009
Report Date
November 25, 2009
Manufacturer
SYNTHES
Product Code
HTY
PMA / PMN Number
K954856
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS DEVICE WAS USED FOR TREATMENT FOR A BONE FRACTURE. THIS INDIVIDUAL ADVERSE EVENT REPORT IS BEING MADE IN ACCORDANCE WITH THE SYNTHES MDR EXEMPTION REQUEST DATED OCTOBER 2011. A REVIEW OF THE EVENTS ASSOCIATED WITH THE REQUEST WAS PERFORMED AND IT WAS DETERMINED THAT NONE OF THE EVENTS CONSTITUTES SYSTEMIC ISSUES RELATED TO PRODUCT QUALITY, CHANGES IN PRODUCT DESIGN, METHOD OF USE, OR CHANGES IN EXPECTED RISK THRESHOLDS. REVIEW OF THE DATA ALSO INDICATED NO SIGNIFICANT CHANGE IN RISK/BENEFIT OF EACH PRODUCT CATEGORY, NO EVIDENCE OF DEFICIENCIES IN THE DESIGN, LABELING, OR MANUFACTURE OF THE DEVICE. AS NO LOT NUMBER WAS PROVIDED, NO DEVICE HISTORY RECORD REVIEW CAN BE PERFORMED. THE DEVICE IS NOT BEING RETURNED FOR EVALUATION, NO FURTHER INFORMATION IS AVAILABLE ON THIS EVENT. NO FURTHER INVESTIGATION CAN BE PERFORMED.

Description of Event or Problem · 1

THE (B)(6) COMPLAINT HANDLING UNIT REPORTED THAT THE NAIL WAS BROKEN POST-OP. THE PATIENT HAD REMAINED IN BED AND CHAIR FOR 2 AND A HALF MONTHS AFTER SURGERY AND WAS THEN MOBILIZED TO PARTIAL WEIGHT BEARING VIA TOE TOUCH. ON (B)(6) 2009, SHE WENT TO ER WITH LEFT HIP PAIN. THE RADIOLOGICAL EVALUATION REVEALED THE NAIL BREAKAGE AT THE PROXIMAL INTERLOCKING SCREW SITE WITH NO SIGN OF THE FRACTURE HEALING. ALL THE POST OPERATIVE RADIOLOGICAL INVESTIGATIONS SHOWED CORRECT PLACEMENT OF NAIL AND FIXATION OF THE FRACTURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CFN Ø12 L380 TAN GREEN CANNULATED FEMORAL NAIL HTY SYNTHES UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention